Fig. 1From: Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic–pharmacodynamic profiles of rivaroxabanFlowchart of the technological process. PK, pharmacokinetic profiles; PD, pharmacodynamic profiles; AXA3h, anti-Xa activity measured 3 h after rivaroxaban administration; AUC0-t: the area under the plasma concentration–time curve from time 0-t h; RT-qPCR: quantitative reverse transcription polymerase chain reaction; RIV: rivaroxabanBack to article page